We are developing radiotracers for early detection of neurodegenerative disorders. This diagnosis is performed using PET imaging to visualize specific brain receptors. We see Nemosia as the missing piece to support drug development, therapy monitoring patient recruitment.

Location

Canton

Facts & figures

  • Type of organization
    Private company
  • Year of foundation
    2022
  • Number of employees in Switzerland
    1-9

Keep browsing

You may also be interested in